Synthesis and iNOS/nNOS inhibitory activities of new benzoylpyrazoline derivatives

Tetrahedron

Volumn 60, Issue 18, 2004, Pages 4051-4069

  Carrión, M Dora ^a   Camacho, M Encarnación ^a   León, Josefa ^b   Escames, Germaine ^b   Tapias, Víctor ^b   Acuña Castroviejo, Darío ^b   Gallo, Miguel A ^a   Espinosa, Antonio ^a  

^a Facultad de Farmacia   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Addition reactions; Antiinflammatory compounds; Benzisoxazoles; Pyrazolines

Indexed keywords

3 (2 AMINO 5 METHOXYBENZOYL) 1 CYCLOHEXANECARBONYL DELTA2 PYRAZOLINE 5 CARBOXYLIC ACID; BENZOYLPYRAZOLINE; CARBOXYLIC ACID DERIVATIVE; ETHYL 3 (2 AMINO 5 METHOXYBENZOYL) 1 BENZOYL DELTA2 PYRAZOLINE 5 CARBOXYLATE; MELATONIN DERIVATIVE; MELATONIN(N ACETYL 5 METHOXYTRYPTAMINE); NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIOTRANSFORMATION; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; EVALUATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 1842680444     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2004.03.013     Document Type: Article

References (33)

1. Hanafy K.A., Knumenacker J.S., Murad F. NO nitrotyrosine and cyclic GMP in signal transduction. Med. Sci. Monit. 7:2001;801-819.
2. Alderton W.K., Cooper C.E., Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357:2001;593-615.
3. Bredt D.S., Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63:1994;175-195.
4. Yew D.T., Wong H.W., Li W.P., Lai H.W., Yu W.H. Nitric oxide synthase in different areas of normal aged and Alzheimer's brains. Neuroscience. 89:1999;675-686.
5. Wong N.K., Strong M.J. Nitric oxide synthase expression in cervical spinal cord in sporadic amyotrophic lateral sclerosis. Eur. J. Cell Biol. 77:1998;338-343.
6. Norris P.J., Waldvogel H.J., Faull R.L., Love D.R., Emson P.C. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Hungtinton's disease. Neuroscience. 4:1996;1037-1047.
7. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1991;1157-1158.
8. McCartney-Francis N., Allens J.B., Mizel D.E., Albina J.E., Nathan C.F., Whal S.M. Suppression of arthritis by an inhibitor of NO synthase. J. Exp. Med. 178:1993;749-754.
9. Moncada S. Nitric oxide: discovery and impact on clinical medicine. J. R. Soc. Med. 92:1999;164-169.
10. Naka M., Nanbu T., Kobayashi K., Kamanaka Y., Komeno M., Yanase R., Fukutomi T., Fujimara S., Seo H.G., Fujiwara N., Ohuchida S., Susuki K., Kondo K., Taniguchi N. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative. Biochem. Biophys. Res. Commun. 270:2000;663-667.
11. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B., Knowles R. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272:1997;4959-4963.
12. Camacho E., León J., Carrión A., Entrena A., Escames G., Khaldy H., Acuña-Castroviejo D., Gallo M.A., Espinosa A. Inhibition of nNOS activity in rat brain by synthetic kynurenines: structure-activity dependence. J. Med. Chem. 45:2002;263-274.
13. Vallence P., Leiper J. Blocking NO synthesis: how, where and why. Drug Discov. 1:2002;939-950.
14. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev. 12:1991;151-180.
15. Rusak B., Yu G.D. Regulation of melatonin-sensitive and firing-rate rhythms of hamster suprachiasmatic nucleus neurons: pinealectomy effects. Brain Res. 602:1993;200-204.
16. Acuña-Castroviejo D., Escames G., Macias M., Muñoz-Hoyos A., Molina-Carballo A., Arauzo M., Montes R., Vives F. Cell protective role of melatonin in the brain. J. Pineal Res. 19:1995;57-63.
17. 2+ epileptiform activity in human temporal slices. Exp. Brain Res. 107:1995;321-325.
18. Marco M., Vincenzo P.P., Gilberto S., Tarzia G. Melatonin. Curr. Med. Chem. 6:1999;501-518.
19. Escames G., Acuña-Castroviejo D., Vives F. Melatonin-dopamine interaction in the striatal projection area of sensorimotor cortex in the rat. NeuroReport. 7:1996;597-600.
20. Pozo D., Reiter R.J., Calvo J.R., Guerrero J.M. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 55:1994;455-460.
21. Bettahi I., Pozo D., Osuna C., Reiter R.J., Acuña-Castroviejo D., Guerrero J. Melatonin reduces nitric oxide synthase activity in rat hipothalamus. J. Pineal Res. 20:1996;205-210.
22. León J., Vives F., Crespo E., Camacho E., Espinosa A., Gallo M.A., Escames G., Acuña-Castroviejo D. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. J. Neuroendocrinol. 10:1998;297-302.
23. León J., Macías M., Escames G., Camacho E., Khaldy H., Martín M., Espinosa A., Gallo M.A., Acuña-Castroviejo D. Structure-related inhibition of calmodulin-dependent neuronal nitric oxide synthase activity by melatonin and synthetic kynurenines. Mol. Pharmacol. 58:2000;967-975.
24. Küçükgüzel Ş.G., Rollas S., Erdeniz H., Kiraz M., Ekinci A.C. Synthesis, characterization and pharmacological properties of some 4-arylhydrazono-2-pyrazoline-5-one derivatives obtained from heterocyclic amines. Eur. J. Med. Chem. 35:2000;761-771.
25. Turan-Zitouni G., Chevallet P., Kiliç F.S., Erol K. Synthesis of some thiazolyl-pirazoline derivatives and preliminary investigation of their hypotesive activity. Eur. J. Med. Chem. 35:2000;635-641.
26. Palaska E., Erol D., Demirdamar R. Synthesis and antidepressant activities of some 1,3,5-triphenyl-2-pyrazolines. Eur. J. Med. Chem. 31:1996;43-47.
27. Solomon W.D., Ravi T.K., Annadurai K. Synthesis of certain substituted 1,2-pyrazolines from phenoxyacetic acid hydrazide and 3,4,5-trimethoxybenzoic acid hydrazide and their possible biological activities. Indian Drugs. 36:1999;466-469.
28. Shimada F., Shiga Y., Morikawa M., Kawazura H., Morikawa O., Matsuoka T., Nishizaki T., Saito N. The neuroprotective agent MS-153 stimulates glutamate uptake. Eur. J. Pharmacol. 386:(2/3):1999;263-270.
29. Fürstner A., Jumbam D., Scidel G. Syntheses of zindoxifene and analogues by titanium-induced oxo-amide cupling. Chem. Ber. 127:1994;1125-1130.
30. Makino K., Takahashi H. The synthesis of 5-hydroxykynurenine. J. Am. Chem. Soc. 76:1954;4994-4996.
31. Shen W., Coburn C., Bornmann W.G., Denishefsky S.J. Concise total syntheses of DL-camptothecin and related anticancer drugs. J. Org. Chem. 58:1993;611-617.
32. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthethase, a calmodulin requiring enzyme. Proc. Natl. Acad. Sci. U. S. A. 87:1990;682.
33. Lowry O.H., Rosebroigh N.J., Farr A.S., Randall R.J. Protein easurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-267.